The frequency of occurrence of heart failure and systemic emboli was studied, as well as the adequacy of antithrombotic therapy (ATT) in 664 patients with non-valvular atrial fibrillation (AF), according to the KRAF hospital register.
Nikolai Gamletovich Gogolashvili +2 more
doaj +1 more source
[The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries]. [PDF]
Salukhov VV +8 more
europepmc +1 more source
Atrial fibrillation is one of the main risk factor of ischemic stroke. Current problems of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke prevention in these patients are considered. Data of own author’
E. A. Drozdova
doaj +1 more source
[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries]. [PDF]
Arutyunov AG +221 more
europepmc +1 more source
Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation
Study goal: to assess levels of TNF-α in blood serum of patients with atrial fibrillation during paroxysm and after the episode. To find possible practical application of measuring TNF-α serum levels as a diagnostic method to detect the onset of paroxysm.
E M Esedov +4 more
doaj
Adherence to drug therapy in patients with atrial fibrillation
We studied treatment adherence in 118 patients with atrial fibrillation (AF) who were between the ages of 45 and 88 years. 63.6% of patients with arrhythmia to take a medicine irregularly.
М A Kachkovskiy, O V Krasnoslobodskaya
doaj
[Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus]. [PDF]
Erlikh AD +8 more
europepmc +1 more source
[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]. [PDF]
Ermolaeva AS, Fadeev VV.
europepmc +1 more source
[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]. [PDF]
Shlyakhto EV +22 more
europepmc +1 more source

